[Significance of surgical treatment for recurrent and metastatic gastrointestinal stromal tumors].

Zhang, X H; He, Y L

Zhang, X H; He, Y L.

Affiliation

Zhang XH; Center of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
He YL; Center of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

Zhonghua Wei Chang Wai Ke Za Zhi ; 23(9): 840-844, 2020 Sep 25.

Article in Zh | MEDLINE | ID: mdl-32927506

Subject(s)

Antineoplastic Agents/therapeutic use; Gastrointestinal Neoplasms/surgery; Gastrointestinal Stromal Tumors/surgery; Imatinib Mesylate/therapeutic use; Neoplasm Recurrence, Local/surgery; Cytoreduction Surgical Procedures; Disease Progression; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms/drug therapy; Gastrointestinal Neoplasms/pathology; Gastrointestinal Stromal Tumors/drug therapy; Gastrointestinal Stromal Tumors/secondary; Humans; Neoplasm Recurrence, Local/drug therapy; Patient Care Team; Sunitinib/therapeutic use; Treatment Outcome; Tumor Burden

Key words

Gastrointestinal stromal tumor; Surgery; Targeted therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors / Imatinib Mesylate / Gastrointestinal Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents Limits: Humans Language: Zh Journal: Zhonghua Wei Chang Wai Ke Za Zhi Year: 2020 Document type: Article

Fulltext

XML

PubMed Links

Search on Google